795 results on '"Nakamura, Yoshiaki"'
Search Results
2. Bridging horizons beyond CIRCULATE-Japan: a new paradigm in molecular residual disease detection via whole genome sequencing-based circulating tumor DNA assay
3. Prediction of undetectable circulating tumor DNA by comprehensive genomic profiling assay in metastatic prostate cancer: the SCRUM-Japan MONSTAR SCREEN project
4. PGC-based cryobanking, regeneration through germline chimera mating, and CRISPR/Cas9-mediated TYRP1 modification in indigenous Chinese chickens
5. Bilateral breast metastases from anaplastic lymphoma kinase-positive lung cancer in a male: a case report
6. A case of BIA-ALCL in which postoperative chest wall recurrence was highly suspected: the third reported case of BIA-ALCL in Japan
7. Different efficacy of tyrosine kinase inhibitors by KIT and PGFRA mutations identified in circulating tumor DNA for the treatment of refractory gastrointestinal stromal tumors
8. Clinical features associated with NeoRAS wild-type metastatic colorectal cancer A SCRUM-Japan GOZILA substudy
9. Genomic profiling and clinical utility of circulating tumor DNA in metastatic prostate cancer: SCRUM-Japan MONSTAR SCREEN project
10. Anomalous enhancement of thermoelectric power factor in multiple two-dimensional electron gas system
11. Efficacy and safety of trifluridine/tipiracil plus ramucirumab in comparison with trifluridine/tipiracil monotherapy for patients with advanced gastric cancer–single institutional experience
12. Appropriate Relevancy and Reliability of Real-World Data for the Utilization of Regulatory Submission
13. Association analysis of production traits of Japanese quail (Coturnix japonica) using restriction-site associated DNA sequencing
14. Preoperative Neutrophil-to-Lymphocyte Ratio in Postmenopausal Breast Cancer Patients
15. Clinical significance of circulating-tumour DNA analysis by metastatic sites in pancreatic cancer
16. Problems Seen from the Awareness on the Introduction and Operation of the Bus Location Systems and Examples of Problem Solving Through the Use of Data
17. Validity and utility of blood tumor mutational burden (bTMB) is dependent on circulating tumor DNA (ctDNA) shed: SCRUM-Japan MONSTAR-SCREEN
18. Molecular residual disease and efficacy of adjuvant chemotherapy in patients with colorectal cancer
19. Phonon diffraction and interference using nanometric features.
20. Molecular Residual Disease-guided Adjuvant Treatment in Resected Colorectal Cancer: Focus on CIRCULATE-Japan
21. Tumor response and survival outcomes of salvage concurrent chemoradiotherapy with three-dimensional conformal radiotherapy and 5-fluorouracil/platinum-based chemotherapy for postoperative locoregional recurrence of esophageal squamous cell carcinoma
22. NOTCH gene alterations in metastatic colorectal cancer in the Nationwide Cancer Genome Screening Project in Japan (SCRUM-Japan GI-SCREEN)
23. Characteristics and clinical outcomes of patients with advanced gastric or gastroesophageal cancer treated in and out of randomized clinical trials of first-line immune checkpoint inhibitors
24. The predictive role of ERBB2 point mutations in metastatic colorectal cancer: A systematic review
25. Thermoelectric properties of B-doped nanostructured bulk diamond with lowered thermal conductivity
26. Inadequate reporting of adjudicators in open-label trials of anticancer drugs between 2017 and 2021: a methodological review
27. Temperature sensitivity of DNA double-strand break repair underpins heat-induced meiotic failure in mouse spermatogenesis
28. Prediction of sex-determination mechanisms in avian primordial germ cells using RNA-seq analysis
29. IMAGENE trial: multicenter, proof-of-concept, phase II study evaluating the efficacy and safety of combination therapy of niraparib with PD-1 inhibitor in solid cancer patients with homologous recombination repair genes mutation
30. Trastuzumab Deruxtecan in Human Epidermal Growth Factor Receptor 2–Expressing Biliary Tract Cancer (HERB; NCCH1805): A Multicenter, Single-Arm, Phase II Trial.
31. Observational study examining the feasibility of generating real-world evidence (RWE) for new drug applications from the clinical trials database (DB; RELIASE study).
32. Circulating tumor DNA for predicting radiographic and pathologic response to total neoadjuvant therapy in locally advanced rectal cancer: ENSEMBLE-1.
33. Correlation of enriched specific subset of immune cells nearby tumor associated macrophage (TAM) with pathologic complete response (pCR) of concurrent chemoradiotherapy followed by nivolumab in locally advanced rectal cancer (LARC).
34. Deciphering the prognostic value of FGFR2b/2c isoform expression levels in advanced esophagogastric cancer through whole-transcriptome sequencing.
35. Circulating tumor DNA-guided treatment with pertuzumab plus trastuzumab for HER2-amplified metastatic colorectal cancer: a phase 2 trial
36. Impact of serum vitamin D on the response and prognosis in breast cancer patients treated with neoadjuvant chemotherapy
37. Efficacy of pembrolizumab in microsatellite instability-high locally advanced cholangiocarcinoma: a case report
38. Quantitative trait loci for growth-related traits in Japanese quail (Coturnix japonica) using restriction-site associated DNA sequencing
39. Biomarker-targeted therapies for advanced-stage gastric and gastro-oesophageal junction cancers: an emerging paradigm
40. Numerical investigation of growth interface shape and compositional distributions in SiGe crystals grown by the TLZ method in the International Space Station
41. Prognostic Value and Molecular Landscape of HER2 Low-Expressing Metastatic Colorectal Cancer
42. Dominant carrier of pseudo-gap antiferromagnet Cr3Al thin film
43. Whole‐transcriptome sequencing in advanced gastric or gastroesophageal cancer: A deep dive into its clinical potential.
44. Lenvatinib plus pembrolizumab in patients with advanced gastric cancer in the first-line or second-line setting (EPOC1706): an open-label, single-arm, phase 2 trial
45. Development of circulating tumour DNA analysis for gastrointestinal cancers
46. Effects of Metastatic Sites on Circulating Tumor DNA in Patients With Metastatic Colorectal Cancer
47. Clinical utility of circulating tumor DNA sequencing in advanced gastrointestinal cancer: SCRUM-Japan GI-SCREEN and GOZILA studies
48. A multicenter phase II study of TAS-114 in combination with S-1 in patients with pretreated advanced gastric cancer (EPOC1604)
49. The clinical usefulness of the CTS5 in the prediction of late distant recurrence in postmenopausal women with estrogen receptor-positive early breast cancer
50. The comparison of the anatomic stage and pathological prognostic stage according to the AJCC 8th edition for the prognosis in Japanese breast cancer patients: data from a single institution
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.